https://www.selleckchem.com/products/bi-4020.html
Cryoballoon (C ablation for pulmonary vein isolation (PVI) is an effective treatment of atrial fibrillation (AF). Recently, a novel cryoablation system was introduced. The aim of the study was to compare the safety, efficacy and biophysical characteristics of a novel cryoablation system (POLARx™; Boston Scientific) to a commonly used and clinically well characterized system (Arctic Front Advance Pro™, AFA; Medtronic). Fifty consecutive patients with symptomatic AF, who underwent CB-based ablation with the POLARx were compared to 50 co
Like
Comment
Share
